← All stocks

DiaMedica Therapeutics Inc.

DMAC Net buying
CIK 0001401040 #3414 in the set updated 18 Sep 2026
Bought (120 mo)
$47.68M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$3.53M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$3.53M
1 of 1 sales
Net
+$44.15M
+$44.15M against sales at will

By person

16 insiders · 75 transactions
1.7×

Rick Pauls holds only 1.7 times base salary in stock. $1.10M of shares against $645.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Rick Pauls last reported holding, valued at $8.57, the price Common Shares was last bought or sold at on the open market here, on 25 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
STAHLBERG JAN
10% owner
$21.99M (18)
+$21.99M
8,825,742
16.37%
$75.68M
+119.5%
Von Koch Thomas
10% owner
$21.80M (5)
$3.53M (1)
+$18.28M
8,383,577
15.55%
$71.89M
+216.6%
JACINTO RICHARD II
10% owner
$1.40M (1)
+$1.40M
4,958,823
9.20%
$42.52M
+8.8%
Wambeke David J.
Chief Business Officer
$949.20K (3)
+$949.20K
527,114
0.9775%
$4.52M
Giuffre Randall Michael
Director
$560.23K (11)
+$560.23K
479,008
0.8883%
$4.11M
+257.1%
Pilnik Richard D.
Director
$399.49K (9)
+$399.49K
312,995
0.5804%
$2.68M
+1,680%
ALCORN HARRY W JR
SVP, Clinical Operations
$145.05K (7)
+$145.05K
43,981
0.0816%
$377.13K
Burroughs Amy L.
Director
$141.59K (1)
+$141.59K
73,288
0.1359%
$628.44K
Pauls Dietrich John
President & CEO
$112.57K (5)
+$112.57K
128,791
0.2388%
$1.10M
+419.2%
Kellen Scott
CFO & Secretary
$103.01K (6)
+$103.01K
32,290
0.0599%
$276.88K
+1,483%
Semba Charles Pauling
Director
$50.00K (1)
+$50.00K
47,963
0.0889%
$411.28K
Xiao Zhenyu
Director
$13.00K (1)
+$13.00K
1,007,100
1.87%
$8.64M
+0.3%
Parsons James T.
Director
$9.00K (1)
+$9.00K
97,949
0.1816%
$839.90K
+2,592%
Verdoorn Todd A.
Chief Scientific Officer
$4.00K (1)
+$4.00K
2,000
0.0037%
$17.15K
+100.0%
Kuntz Richard
Director
24,210
0.0449%
$207.60K
Gilman Sydney A.
VP, Regulatory Affairs
0
0.0000%
$0.00
Insider
Date
Role
Action
Shares
Price
Amount
Parsons James T.
21 Nov 2025
Director
Exercised, kept
12,000
$2.20
$26.40K
Pilnik Richard D.
7 Apr 2025
Director
Exercised, kept
24,000
$2.11
$50.64K
Giuffre Randall Michael
13 Feb 2025
Director
Exercised, kept
5,000
$3.65
$18.25K
Giuffre Randall Michael
13 Feb 2025
Director
Exercised, kept
12,000
$2.11
$25.32K

What was left out

Form 4 filings counted 153
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 537,701
Sales filed before the plan box existed 1
History held since 11 Dec 2018